- Home
- MIST vs ZYBT Comparison
MIST vs ZYBT Comparison
Compare MIST & ZYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- ZYBT
- Stock Information
- Founded
- MIST 2003
- ZYBT 2004
- Country
- MIST Canada
- ZYBT China
- Employees
- MIST N/A
- ZYBT N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- ZYBT
- Sector
- MIST Health Care
- ZYBT
- Exchange
- MIST Nasdaq
- ZYBT NYSE
- Market Cap
- MIST 89.8M
- ZYBT 340.3M
- IPO Year
- MIST N/A
- ZYBT 2025
- Fundamental
- Price
- MIST $1.92
- ZYBT $5.88
- Analyst Decision
- MIST Strong Buy
- ZYBT
- Analyst Count
- MIST 2
- ZYBT 0
- Target Price
- MIST $7.50
- ZYBT N/A
- AVG Volume (30 Days)
- MIST 613.1K
- ZYBT 449.3K
- Earning Date
- MIST 08-07-2025
- ZYBT 01-01-0001
- Dividend Yield
- MIST N/A
- ZYBT N/A
- EPS Growth
- MIST N/A
- ZYBT N/A
- EPS
- MIST N/A
- ZYBT 0.06
- Revenue
- MIST N/A
- ZYBT $26,111,272.00
- Revenue This Year
- MIST N/A
- ZYBT N/A
- Revenue Next Year
- MIST N/A
- ZYBT N/A
- P/E Ratio
- MIST N/A
- ZYBT $108.13
- Revenue Growth
- MIST N/A
- ZYBT N/A
- 52 Week Low
- MIST $0.63
- ZYBT $3.50
- 52 Week High
- MIST $2.75
- ZYBT $14.30
- Technical
- Relative Strength Index (RSI)
- MIST 67.01
- ZYBT N/A
- Support Level
- MIST $1.85
- ZYBT N/A
- Resistance Level
- MIST $2.02
- ZYBT N/A
- Average True Range (ATR)
- MIST 0.09
- ZYBT 0.00
- MACD
- MIST 0.01
- ZYBT 0.00
- Stochastic Oscillator
- MIST 73.75
- ZYBT 0.00
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About ZYBT ZHENGYE BIOTECHNOLOGY HLDG LTD
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.